71 – 76 of 76
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2000
-
Mark
Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies
(
- Contribution to journal › Article
- 1999
-
Mark
A comparison of genome-scans performed in multicase families with systemic lupus erythematosus from different population groups
(
- Contribution to journal › Article
-
Mark
Synergetic effect between interleukin-1 receptor antagonist allele (IL1RN*2) and MHC class II (DR17,DQ2) in determining susceptibility to systemic lupus erythematosus
(
- Contribution to journal › Article
- 1995
-
Mark
Sharing of MHC haplotypes among patients with systemic lupus erythematosus from unrelated Caucasian multicase families: disease association with the extended haplotype [HLA-B8, SC01, DR17]
(
- Contribution to journal › Article
- 1993
-
Mark
Antiproliferative effects on human peripheral blood mononuclear cells and inhibition of in vitro immunoglobulin synthesis by Podophyllotoxin (CPH86) and by semisynthetic lignan glycosides (CPH82)
(
- Contribution to journal › Article
- 1987
-
Mark
Hyaluronidase treatment of synovial fluid affects the recovery of mononuclear cells and their in vitro immunoglobulin synthesis
(
- Contribution to journal › Article